The Prognostic Impact of Main Bronchial Lymph Node Involvement in Non-Small Cell Lung Carcinoma: Suggestions for a Modification of the Staging System

Annals of Thoracic Surgery

Volumn 88, Issue 5, 2009, Pages 1583-1588

  Shimada, Yoshihisa ^a   Tsuboi, Masahiro ^a   Saji, Hisashi ^a   Miyajima, Kuniharu ^a   Usuda, Jitsuo ^a   Uchida, Osamu ^a   Kajiwara, Naohiro ^a   Ohira, Tatsuo ^a   Hirano, Takashi ^a   Kato, Harubumi ^a   Ikeda, Norihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; DISTANT METASTASIS; FEMALE; GENDER; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; LUNG TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE;

EID: 70449732627     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.04.065     Document Type: Article

References (23)

1. Mountain C.F. A new international staging system for lung cancer. Chest 89 (1986) 225S-233S
2. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
3. Watanabe S., Ladas G., and Goldstraw P. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. Ann Thorac Surg 73 (2002) 245-248 discussion 248-9
4. Cancer AJCC. Clinical staging system for carcinoma of the lung (1973), American Joint Committee for Cancer Staging and End Results Reporting, Chicago
5. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 832-839
6. American Thoracic Society. Medical section of the American Lung Association. Clinical staging of primary lung cancer. Am Rev Respir Dis 127 (1983) 659-664
7. Kato H., Kwade N., Kobayashi K., et al. Classification of lung cancer. The Japan Lung Cancer Society. 1st English ed. (2000), Kanehara Co, Ltd, Tokyo 6-14
8. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
9. Thomas M., Rube C., Hoffknecht P., et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 9 (2008) 636-648
10. van Meerbeeck J.P., Kramer G.W., Van Schil P.E., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
11. Asamura H., Suzuki K., Kondo H., and Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer?. Ann Thorac Surg 70 (2000) 1839-1845 discussion 1845-6
12. Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., and Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 107 (1994) 1398-1402
13. van Velzen E., Snijder R.J., Brutel de la Riviere A., Elbers H.R., and van den Bosch J.M. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. Ann Thorac Surg 63 (1997) 1436-1440
14. Marra A., Hillejan L., Zaboura G., Fujimoto T., Greschuchna D., and Stamatis G. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 125 (2003) 543-553
15. Caldarella A., Crocetti E., Comin C.E., Janni A., Pegna A.L., and Paci E. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications. Cancer 107 (2006) 793-798
16. Okada M., Sakamoto T., Yuki T., et al. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg 129 (2005) 825-830
17. Riquet M., Manac'h D., Le Pimpec-Barthes F., Dujon A., and Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 67 (1999) 1572-1576
18. Ueda K., Kaneda Y., Saeki K., Fujita N., Zempo N., and Esato K. Hilar lymph nodes in N2 disease: survival analysis of patients with non-small cell lung cancers and regional lymph node metastasis. Surg Today 32 (2002) 300-304
19. Matsuoka K., Sumitomo S., and Misaki N. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung. J Thorac Oncol 2 (2007) 1098-1102
20. Martini N., Burt M.E., Bains M.S., McCormack P.M., Rusch V.W., and Ginsberg R.J. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 54 (1992) 460-465 discussion 466
21. Osaki T., Nagashima A., Yoshimatsu T., Tashima Y., and Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43 (2004) 151-157
22. Rusch V.W., Crowley J., Giroux D.J., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 603-612
23. Ueda K., Kaneda Y., Sakano H., et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg 51 (2003) 297-301